2 Executive Orders Aim to Lower Prescription Drug Prices

President Donald Trump recently issued two executive orders (EOs) that pertain to pharmaceuticals in the United States. The first, released on May 5, is focused on increasing U.S.-based pharmaceutical manufacturing. The second EO, published on May 12, aims to reduce drug prices by tying what U.S. consumers pay for drugs to typically lower prices buyers are charged in many countries outside the United States.

But both EOs may need congressional action and could face legal challenges, experts